hospitalised – Page 11 – Communicable Diseases Research

Older patients’ perspectives on illness and healthcare during the early phase of the COVID-19 pandemic

Empirical Paper

Published on 2022-03-032022-10-31
Journal: Nursing Ethics [Category] COVID-19, MERS,

Clinical Outcomes in Patients Aged 80 Years or Older Receiving Non-Invasive Respiratory Support for Hypoxemic Acute Respiratory Failure Consequent to COVID-19

Article

Published on 2022-03-022022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

입원한 COVID-19 폐렴 환자에 대한 렌질루맙(LIVE-AIR): 3상, 무작위, 위약 대조 시험

Clinical Trial

Published on 2022-03-012022-09-12
Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 진단,

[키워드] 1:1 95% CI added Administered Adverse adverse event age assigned baseline Brazil C-reactive protein concentration cardiac disorder contribute Corticosteroids COVID-19 criteria CTCAE cytokine death demographics disease severity dose double-blind Efficacy and safety enrolled event GM-CSF granulocyte-macrophage colony-stimulating factor greater groups hazard ratio hospitalised hospitalised patient hyperinflammation Immune-mediated immunomodulator include Inflammatory intention-to-treat population intravenous dose Invasive mechanical ventilation investigated investigator IQR likelihood males median mITT mITT analysis modified intention-to-treat monoclonal antibody neutralising participant pathophysiology Patient patients with COVID-19 Phase 3 Placebo placebo-controlled trial Pneumonia primary endpoint Primary outcome randomisation randomised Randomly receive recruited Registered Remdesivir respiratory disorder Respiratory failure safety profile screened severity significantly standard supportive care steroid stratified study drug survival the placebo group treat treating COVID-19 treatment-emergent adverse event Trial USA were assessed with COVID-19
[DOI] 10.1016/S2213-2600(21)00494-X PMC 바로가기 [Article Type] Clinical Trial

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients

Observational Study

Published on 2022-03-012022-10-04
Journal: European Journal of Hospital Pharmacy [Category] SARS, 임상,

[키워드] activities Admission Adverse adverse event age Anti-inflammatory Baricitinib C-reactive protein clinical clinical benefit Clinical improvement Corticosteroid COVID-19 Critical Critical care Cytokine storm syndrome education Effectiveness event Evidence-based medicine ferritin hospital discharge hospitalised hospitalised patient immunomodulator improvement inhibitor interleukin-6 IQR laboratory parameter limitation Lymphocytes men Patient Pharmacy Platelet poor prognosis pulmonary medicine Randomised trial reported Retrospective study risk factor severe COVID-19 survival Time to recovery treated Treatment viral endocytosis Virology
[DOI] 10.1136/ejhpharm-2021-002741 PMC 바로가기 [Article Type] Observational Study

Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study

Observational Study

Published on 2022-02-282022-10-04
Journal: BMJ Open [Category] COVID19(2023년), SARS, 임상,

[키워드] 95% CI adverse outcomes age all-cause mortality Antiviral change changed Characteristics Clinical diagnosis Clinical outcome clinical outcomes Cohort cohort study cohorts COVID-19 COVID-19 patient cumulative death Decline declined Dexamethasone Electronic health records elevated Epidemiology flat hospital hospitalised hospitalised patient In-hospital In-hospital death incidence incident Laboratory Observational cohort study outcome Patient positive proportion public health remained risk secondary outcome subset the disease the median Treatment trend USA use of hydroxychloroquine with COVID-19 women
[DOI] 10.1136/bmjopen-2021-055137 PMC 바로가기 [Article Type] Observational Study

Clinical Features and Changes in Insulin Requirements in People with Type 2 Diabetes Requiring Insulin When Hospitalised with SARS-CoV-2 Infection

Research Article

Published on 2022-02-262022-10-30
Journal: International Journal of Endocrinology [Category] COVID-19,

Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study

Observational Study

Published on 2022-02-252022-10-05
Journal: BMJ Open [Category] COVID19(2023년), SARS, 임상,

Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX study

Observational Study

Published on 2022-02-242022-10-04
Journal: The European Respiratory Journal [Category] COVID19(2023년), SARS, 임상,

Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes—a multicentre cohort study

Research Article

Published on 2022-02-232022-10-28
Journal: BMC Medicine [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS,

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England

Research Article

Published on 2022-02-222022-10-29
Journal: PLoS Medicine [Category] COVID-19, COVID19(2023년), SARS,

[키워드] absolute increase Accuracy adjusted Adults age age and sex analysed Analysis anticoagulant medication antiplatelet Asian association black blood pressure BNT162b2 BNT162b2 vaccines case finding ChAdOx1 ChAdOx1-S coded cohort study confidence interval confounding factors Coronavirus infection covariate covariates COVID-19 COVID-19 mortality COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Deprivation diabetes diagnostic dose DVT Effect effort Electronic health record Electronic health records England estimate estimates event first vaccination Frequency hazard ratio healthcare Hospital admission hospitalisation hospitalised HRs hypertension identify IMPROVE incidence incidence rate increase in increased risk increases in limitation medication morbidity morbidity and mortality Myocardial infarction outcome performed Platelet population level population-based cohort Positive predictive value prevaccination Rate reducing reported researcher residual confounding risk selected Sex smoking stroke therapy threshold thrombosis thrombotic event Thrombotic events vaccination Vaccine Vaccines venous Venous thrombosis white William
[DOI] 10.1371/journal.pmed.1003926 PMC 바로가기 [Article Type] Research Article